Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Toooo much proof in this pudding.....I BELIEVE....AND IF YOU BELIEVE IN ANYTHING... YOU WILL STICK WITH IT AND SEE IT THROUGH!
AMBS
http://www.bloomberg.com/article/2013-04-15/aSOD_4jDeYFM.html
This email is compliments of Scottrade.com
News for 'AMBS' - (Amarantus Taps Russell Miller as Director of Investor Relations)
Apr 25, 2013 (Close-Up Media via COMTEX) -- Amarantus BioScience Holdings,
Inc., a biotechnology company discovering and developing treatments and
diagnostics for diseases associated with the neurodegeneration and apoptosis,
announced that it has appointed Russell Miller as Director of Investor
Relations.
In a release, the Company said that Miller previously served as Director of
Investor Relations for US Data Works and for Force Protection, Inc. He has
assisted in raising capital for companies both public and private, including
real estate financing, development, and joint ventures for over 20 years. He has
successfully participated in private placements, mezzanine financing, joint
ventures, mergers and acquisitions, reverse mergers, national exchange
up-listings and acquisitions for companies on the OTC, AMEX, and NASDAQ. As a
consultant Miller has assisted a multitude of companies by developing their
strategic plans for growth, liquidity, and return on equity by facilitating
relationships with investment bankers, government relations officers,
financiers, the media, and marketing and public relation firms. He has a broad
range of worldwide contacts throughout the investment banking community, which
include a large number of accredited investors and investment institutions.
Happy Birthday MUKA!
Blessings to see many more!
Chelby84
UNGS.... He has a better chance of breaking outa jail than breaking .0001's!
CHETRA.. my pants are down waiting on this one.... and I have lost my pom poms.
Maybe you can get early release for good behavior!!
UNGS
Shares are not available to trade with Scottrade. On the phone with the broker this morning and was told the TA has not delivered shares to Scottrade. Unable to trade AMBS today!!! or at least at this moment.
AMBS
Are you soliciting for Maxim Group? How are much will you be paid?
AMBS
http://www.sbwire.com/press-releases/explosive-penny-stocks-amarantus-bioscience-holdings-inc-otcambs-w2-energy-inc-goff-corp-undersea-recovery-co-240195.htm
Stamford, CT -- (SBWIRE) -- 04/19/2013 -- Jet Life Penny Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletters and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTC:AMBS), W2 Energy, Inc. (PINK:WTWO), Goff Corp (OTC:GOFF), UNDERSEA RECOVERY CO (PINK:UNDR)
AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTC:AMBS) stock is at $0.0635, and its previous close of $0.0635. The stock opened the session at $0.0.08 and touched its highest price point at $0.08. AMBS stock’s lowest price point for the session stood at $0.06.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative -38.94% during the previous three months trade. Its total trading volume is 7.92 million shares for the day, in comparison to its average trading volume of 4.54 million shares.
Can Investors Bet on AMBS after this News update? Find out in this Research Report
DRAMA !!!!!... JUST LIKE THE HOUSE OF PAYNE!
AMBS
This is an investment I will have to turn away as if it did not exist (10K DOLLARS)!
See everyone at the finish line a year or two.
GLT ALL
What happened?? Can a board just disappear in front of you and no past history of posts?
UNGS
GOD HEARD YA!
UNGS
Is the company still actively in business?
Chelby84
It is an introduction.
AMBS
When is the next run will be ready for lift off? Still gotta bag too for free $$$ made off pretty well! just like madoff.... most people made off$$$ pretty well last summer! U SEE.... IT STARTED ABOUT MAY... JUNE... JULY.. AND AUGUST 2012...BY SEPTEMBER IT WAS OVER...sorry if you got in on the high of the hype...BUT....HOLD ON.. HOLD'EM TIGHT...IT WILL RUN AGAIN....WASH . RINSE.. AND REPEAT... THIS IS WHY WE ARE IN PINKY LAND!!! it took me a long time to get over my loses... but, i realized where i was playing..."stinky pinkies"..WHEN YOU ARE IN ROME.. U DO WHAT THE ROMANS DO; IN PINK LaND TAKE THE PROFITS AND RUN LIKE HELL... DONT HANG AROUND AND MARRY THE STOCK!
goo BBDA
Scottrade only allows from a point in current pps to a pps that is not far from the current pps.
I called the broker yesterday, and she stated she'd place me on hold while she speak to the mm...this was pre-market hour yesterday morning. The broker returned to the phone and stated the MM accepted/placed my order for 10k @ $3.; and a second order for 20k@ $10. ....... my head is still spinning..AM I DREAMING? I REALLY WANT TO ACCUMULATE MORE SHARES FOR LONG TERM!!!
AMBS
That's about it! Very good one..on the other handwink wink.. called me broker yesterday she put me on hold and stated she'd speak wid the mm to see if he'd take me order 20k@ $10pps...de mm gladly took me order..now await n see to execution..8cents to ten dollars is a long stretch though order made..just curious!
gooo UNGS
Chetra744.. so much for rallying the troops! There are alot of other places to be right about now! and this cheerleader must say, "it sure is not happening here right now?"
'Bout ready to get caught up with my pants down.. or whatever? There is Another cafe' serving it up Chetra'..
Now, can the Andersons' sell shares at a higher pps than .0001 ??? WE SHOULD HAVE BOUGHT UP THE DARN FLOAT BY NOW!!! THERE ARE ALOT OF PEOPLE HOLDING 100 MIL... AND MUCH MORE OF THIS ALL @ .0001...AND THEY STILL HAVE THE BALLS TO HAVE MORE .0001'S REMAINING TO SELL??? LONG IS LONG... BTW?? HOW LONG.??.. THIS IS RIDICULOUS !!!
anyone wants to buy a few blocks or two??? the andersons' are not selling them.... I AM !
UNGS
Can they hear any OIL AND GAS yet?
UNGS
My sentiments exactly!! "I BELIEVE!; I BELIEVE WE WILL ALL FOLLOW THIS YELLOW BRICK ROaD; I BELIEVE THIS ACORN WILL SPROUT INTO TREES.. AND I BELIEVE WE GET OFF THIS ISLAND OF PENNIES' !!
BUT....YOU CAN HAVE MY 98K SHARES @ $10. dollars..A lady knows when to exit$$ GREED IS NOT MY STANDARDS..a win is a win; a gain is a gain; amd so is a LOSS A LOSS!
AMBS
NEWS !..CONFERENCE CALL
This email is compliments of Scottrade.com
News for 'AMBS' - (Amarantus BioScience Schedules Business Update Conference Call)
Apr 10, 2013 (Close-Up Media via COMTEX) -- Amarantus BioScience, Inc., a
biotechnology company discovering and developing treatments and diagnostics for
diseases associated with neurodegeneration and apoptosis, announced it will hold
a conference call on Tuesday, April 16, at 4:30 p.m. Eastern (1:30 p.m. Pacific)
to provide an update on its business and conduct a question and answer session
with investors.
In a release, the company noted that individuals interested in listening to the
conference call may do so by dialing 877-407-8033, or for international callers
201-689-8033. The call is also being webcast, and can be accessed from the
Company's Web site (www.amarantus.com) and at www.InvestorCalendar.com.
A telephone replay will be available through May 1, by dialing 877-660-6853, or
for international callers 201-612-7415, and entering the Conference ID #:
411612. The webcast replay will be available for 90 days following the
completion of the call.
During the call Amarantus Chief Executive Officer Gerald Commissiong will recap
key accomplishments of 2012 and the first quarter of 2013, provide clarity on
the Company's recently updated business model and discuss business and product
development initiatives planned for the remainder of 2013.
Amarantus BioScience, Inc. is a development-stage biotechnology company.
More Information:
http://www.Amarantus.com
UNGS AND I HAVE AN ANNIVERSARY REAL SOON! WE WON'T BE IN THE TRIP'S FOR SURE TO CELEBRATE$$
UNGS
UNGS..WIN$$$ WIN$$ from the bottom$$$ going upwards instead of the top$ going downward$
UNGS
VERY GOOD POINT EXACTLY !!!... YET, JUST LIKE THE BLACKJACK AND CRAP TABLES...PUT YOUR BALLS (i mean your money) on the tables.. and let the chips fall where ever they mAy!
ungs
UNGS: We will soon dine in the UNGS Cafe'....coffie anyone?
News is out!! JV... The company is currently profitable! Investors will see their returns very soon. IMHO
UNGS
KEEP HOPE ALIVE!!! KEEP HOPE ALIVE!!! JUST KEEP 'ON BELIEVING?? KEEP HOPE ALIVE... KEEP HOPE ALIVE
Follow the yellow brick road; ET will find it's way home; SKIPPER AND GILLIGN will get off this ISLAND!!!! LMAO!
BMSN
BMSN:LIKE HELL THIS AIN'T FUNNY??? CHIT!!! DIS IZ SUM FUNNY aZZ CHIT!!! BOLMAO!!!
LOOKS LIKE WE'RE BAG HOLDERS!! CAN'T YOU SEE THE HUMOR IN THAT? LMAO!
IF YOU CAN'T SEEM TO LAUGH @ YOURSELF... THAN, THAT'S WHEN IT HURTS WHEN OTHER'S LAUGH @ YOU TOOO~~~
BMSN: Funny azz Heck....But soooo TRUE!!
Ya think dis ting is go'n back to trip's .000's?
NEWS OUT !!
This email is compliments of Scottrade.com
News for 'AMBS' - (Amarantus Outlines LymPro Alzheimer's Diagnostic Development Strategy)
SUNNYVALE, Calif., Apr 08, 2013 (BUSINESS WIRE) -- Amarantus BioScience
Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing
treatments and diagnostics for diseases associated with neurodegeneration and
apoptosis, today announced a development timeline for its LymPro Blood Test for
Alzheimer's disease
("LymPro"). LymPro is
designed to diagnose Alzheimer's disease by
identifying immune-based biomarkers in the blood of
Alzheimer's patients, allowing physicians to
definitively differentiate Alzheimer's disease from
other forms of dementia, a key unmet medical need in the management of
Alzheimer's patients. Human clinical studies for
LymPro with over 160 patients have been completed to date, showing high
sensitivity and specificity for Alzheimer's disease
diagnosis.
"The LymPro assay represents a blood-based peripheral
means to assess the integrity of the regulatory function of the cellular
machinery within the Central Nervous System," said
Amarantus corporate advisor Adam J. Simon, Ph.D.
"Although we all experience various triggers and
assaults on our brain as we age, why do some people succumb to
Alzheimer's while others show cognitive resilience?
The LymPro test can potentially tell us who is susceptible to abnormal
cell-cycle re-entry and who has sufficiently strong regulatory function in their
neurons to arrest cell-cycle re-entry due to triggers such as age, diet, viral
infection, stress, or brain injury that could eventually lead to
Alzheimer's disease."
After establishing the analytical performance of the assay in an outsourced GLP
laboratory, Amarantus plans to conduct a small clinical performance study at an
independent laboratory in the second quarter of 2013 to verify the previously
published findings. During the third quarter of 2013, the Company expects to
initiate a pivotal diagnostic accuracy study (Phase 2) at the same independent
laboratory to generate sufficient data to validate the clinical performance
(sensitivity / specificity) that would support a CLIA launch, with data
available in the first half of 2014. As part of that pivotal study, LymPro will
be evaluated as an "aid to the diagnosis of
Alzheimer's disease." The
Company intends to initiate commercial worldwide sales following assessment of
the validation study data. Thereafter, the Company intends to gain U.S.
clearance or approval for the test through the Food and Drug
Administration's de-novo Pre-market notification
510(k) or Premarket Approval (PMA) process, which would represent a 3-month to
2-year process. Ultimately, the Company believes LymPro could be approved by the
FDA as a companion diagnostic product in combination with one or more
therapeutic products.
"We are excited with the progress and upcoming
activities related to our LymPro Alzheimer's test,
which addresses a market opportunity in excess of $500 million
annually," said Gerald E. Commissiong, President and
Chief Executive Officer of Amarantus. "The FDA has
stated the importance of identifying Alzheimer's at
the earliest stage, as that is where new treatments appear to have the greatest
benefit to patients. We believe LymPro fits well within this overall strategy
and will likely have the dual benefit of improving overall diagnosis paradigms
and accuracy, while also potentially reducing overall healthcare costs if
combined with an appropriate therapeutic product as a companion
diagnostic."
The field of diagnostics for Alzheimer's disease has
been significantly bolstered in recent months with FDA guidance for drug
developers to target experimental therapies of
Alzheimer's disease towards earlier-stage patients,
as well as guidance reducing the burden of proof for drug developers to gain an
approval. In 2010 Eli Lilly & Co. acquired
Alzheimer's diagnostic developer Avid
Radiopharmaceuticals for $800 million, including $300 million up-front,
following Avid's application for marketing approval
to the FDA for florbetapir, a chemical agent used in the diagnosis of
Alzheimer's disease during a PET imaging process.
Amarantus believes that LymPro may have certain advantages over florbetapir,
including the likely cost-effectiveness of LymPro as a simple blood test in
comparison to more expensive neuro imaging techniques.
About Amarantus
Amarantus is a development-stage biotechnology company founded in January 2008.
The Company is focused on developing unique products and proprietary
technologies for the potential treatment and/or diagnosis of Parkinson's
disease, Traumatic Brain Injury, Ischemic Heart Disease and other human
diseases. The Company owns the intellectual property rights to
Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing
MANF-based products as treatments for neurological disorders where there is a
significant unmet medical need. The Company also is a Founding Member of the
Coalition for Concussion Treatment (#C4CT), a movement initiated in
collaboration with Brewer Sports International seeking to raise awareness of new
treatments in development for concussions and related nervous-system disorders.
For further information please visit www.Amarantus.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements include, but
are not limited to, statements about the possible progress of the MANF
technology in testing for Parkinson's disease,
statements about expectations, plans and prospects of the development of
Amarantus' diagnostic product candidates for
Alzheimer's and
Parkinson's disease, and the potential market size
for the LymPro test for Alzheimer's disease. These
forward-looking statements are subject to a number of risks, uncertainties and
assumptions, including the risks associated with development of therapeutic drug
candidates, as well as the risks, uncertainties and assumptions relating to the
development of Amarantus' new product candidates, including those identified
under "Risk Factors" in Amarantus' most recently filed Annual Report on Form
10-K and Quarterly Report on Form 10-Q and in other filings Amarantus
periodically makes with the SEC. Actual results may differ materially from those
contemplated by these forward-looking statements Amarantus does not undertake to
update any of these forward-looking statements to reflect a change in its views
or events or circumstances that occur after the date of this presentation.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130408005612r1&sid=cmtx4&distro=nx
SOURCE: Amarantus BioScience Holdings, Inc.
CONTACT:
Investor/Media Contact
LHA
Don Markley, Senior Vice President
310.691.7100
dmarkley@lhai.com
Copyright Business Wire 2013
-0-
UNGS All is good! We're holding up just fine...Have'nt lost a dime!
UNGS
Why would you want to tell anyone what your intended positions are? You're only enticing others to get in And out before you!!! You will be out of shares to trade whilst the large BLOCK HEADS trad'em to beyond a PENNY. .01 (ONE CENT AND MORE$$$)
UNGS
Most have been holding lotto UNGS since August 2012
Is it Monday yet? can't sleep; can't wait; nEXT week should start tonite! Would someone please RING THE OPENING BELL? lET'S GO CAFE AMB*
That's right Ungs has to eat while we dine in CAFES'
Go UNGS
Chetra744....behave... you just got outA the pen! GOOD BEHAVIOR ..REMEMBER?
Management is buying from management.....To keep this SCAM ALIVE!
Wonder about that?
place an order for 42 mil shares.... and @ the computer right beside me....I place a buy and sell order for 42 mil shares.
WOW... REALLY MAKING ME WONDER?.... SOMEONE KNOWS SOMETHING THAT WE DONT ! WOW.... I AM WONDERING TOOO...LMAO!!!
Got in @ .03
Since you're the man inquiring; I hope you're the man buying as well!
LUDG
You are only a loser when you sell like a loser! So I'm holding like a bag holder! lol
Patience will be rewarded greatly here!
UNGS
Lol...lmbo!
:)
UNGS
Yes!.. and they are DRUNK TOO ON UNGS !